BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 25683509)

  • 41. Soluble Aβ aggregates can inhibit prion propagation.
    Sarell CJ; Quarterman E; Yip DC; Terry C; Nicoll AJ; Wadsworth JDF; Farrow MA; Walsh DM; Collinge J
    Open Biol; 2017 Nov; 7(11):. PubMed ID: 29142106
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An astrocyte cell line that differentially propagates murine prions.
    Tahir W; Abdulrahman B; Abdelaziz DH; Thapa S; Walia R; Schätzl HM
    J Biol Chem; 2020 Aug; 295(33):11572-11583. PubMed ID: 32561641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The H187R mutation of the human prion protein induces conversion of recombinant prion protein to the PrP(Sc)-like form.
    Hosszu LL; Tattum MH; Jones S; Trevitt CR; Wells MA; Waltho JP; Collinge J; Jackson GS; Clarke AR
    Biochemistry; 2010 Oct; 49(40):8729-38. PubMed ID: 20718410
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prion protein and lipid rafts.
    Taylor DR; Hooper NM
    Mol Membr Biol; 2006; 23(1):89-99. PubMed ID: 16611584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of quality control proteins reduces prion conversion in prion-infected cells.
    Thapa S; Abdulrahman B; Abdelaziz DH; Lu L; Ben Aissa M; Schatzl HM
    J Biol Chem; 2018 Oct; 293(41):16069-16082. PubMed ID: 30154245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Critical significance of the region between Helix 1 and 2 for efficient dominant-negative inhibition by conversion-incompetent prion protein.
    Taguchi Y; Mistica AM; Kitamoto T; Schätzl HM
    PLoS Pathog; 2013; 9(6):e1003466. PubMed ID: 23825952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonneuronal cellular prion protein.
    Fournier JG
    Int Rev Cytol; 2001; 208():121-60. PubMed ID: 11510567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recombinant human prion protein mutants huPrP D178N/M129 (FFI) and huPrP+9OR (fCJD) reveal proteinase K resistance.
    Gauczynski S; Krasemann S; Bodemer W; Weiss S
    J Cell Sci; 2002 Nov; 115(Pt 21):4025-36. PubMed ID: 12356908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation of polydispersed prion protein and characteristic pathology in the thalamus in variant Creutzfeldt-Jakob disease: implication of small oligomeric species.
    Choi YP; Gröner A; Ironside JW; Head MW
    Brain Pathol; 2011 May; 21(3):298-307. PubMed ID: 21029243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detergent-resistant membrane domains but not the proteasome are involved in the misfolding of a PrP mutant retained in the endoplasmic reticulum.
    Campana V; Sarnataro D; Fasano C; Casanova P; Paladino S; Zurzolo C
    J Cell Sci; 2006 Feb; 119(Pt 3):433-42. PubMed ID: 16443748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of GPI-anchored PrP C in mediating the neurotoxic effect of scrapie prions in neurons.
    Radford HE; Mallucci GR
    Curr Issues Mol Biol; 2010; 12(2):119-27. PubMed ID: 19767655
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathologic prion protein infects cells by lipid-raft dependent macropinocytosis.
    Wadia JS; Schaller M; Williamson RA; Dowdy SF
    PLoS One; 2008; 3(10):e3314. PubMed ID: 19390657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of an intracellular site of prion conversion.
    Marijanovic Z; Caputo A; Campana V; Zurzolo C
    PLoS Pathog; 2009 May; 5(5):e1000426. PubMed ID: 19424437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.
    Altmeppen HC; Prox J; Puig B; Dohler F; Falker C; Krasemann S; Glatzel M
    FEBS J; 2013 Sep; 280(18):4338-47. PubMed ID: 23413979
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trapping prion protein in the endoplasmic reticulum impairs PrPC maturation and prevents PrPSc accumulation.
    Cardinale A; Filesi I; Vetrugno V; Pocchiari M; Sy MS; Biocca S
    J Biol Chem; 2005 Jan; 280(1):685-94. PubMed ID: 15513919
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quaternary Structure Changes for PrP
    Eskandari-Sedighi G; Cortez LM; Yang J; Daude N; Shmeit K; Sim V; Westaway D
    Mol Neurobiol; 2021 Jan; 58(1):375-390. PubMed ID: 32959170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells.
    Shim SY; Karri S; Law S; Schatzl HM; Gilch S
    Sci Rep; 2016 Feb; 6():21658. PubMed ID: 26865414
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of lipid rafts in prion protein biology.
    Lewis V; Hooper NM
    Front Biosci (Landmark Ed); 2011 Jan; 16(1):151-68. PubMed ID: 21196164
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of nonconvertible PrPc delta114-121 in scrapie-infected mouse neuroblastoma cells leads to trans-dominant inhibition of wild-type PrP(Sc) accumulation.
    Hölscher C; Delius H; Bürkle A
    J Virol; 1998 Feb; 72(2):1153-9. PubMed ID: 9445012
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prion protein-Semisynthetic prion protein (PrP) variants with posttranslational modifications.
    Hackl S; Becker CFW
    J Pept Sci; 2019 Oct; 25(10):e3216. PubMed ID: 31713950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.